We cannot be caught off guard and risk watching innovative therapies suffocate at the hands of a regulatory system that has not kept up or further cripple the regulatory system by the approval of products that inherently are unsafe.
Burgess emphasizes the need for a responsive regulatory system to support innovative therapies.
Share
More from Michael Burgess
This is a national emergency. This is something we have got to address and save Americans, 200 every day.
I will simply underscore the fact that entry- level chemists at the EPA are hired at much higher than the GSA rate. These are not highly sought-after scientists. These are entry-level applicants, and there is no shortage of applicants for…
For the purpose of debate only, I yield the customary 30 minutes to the gentleman from Massachusetts (Mr. McGovern), pending which I yield myself such time as I may consume. During consideration of this resolution, all time yielded is for…
For the purpose of debate only, I yield the customary 30 minutes to the Congresswoman from Pennsylvania (Ms. Scanlon), pending which I yield myself such time as I may consume. During consideration of this resolution, all time yielded is…
Other voices in this conversation
